ADORED-Allergic Disease Onset Prevention Study  

Siolta Therapeutics is testing this investigational drug for the prevention of allergic diseases, including atopic dermatitis (eczema), food allergy, asthma, and allergic rhinitis (hay fever). 

Test RTE

Study Overview Study Details Eligibility Trial Primary Objective:To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)Secondary Objectives:To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivationTo continue to …

Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)

Primary Objectives:To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable.To evaluate the time-course of AD and selected atopic comorbidities.

None

None

None

None

None

None

None